Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)Makoto Yamasaki, Yuichiro� Doki, Takushi Yasuda et al.|Annals of Oncology|2016Cited by 128
Randomized study of the clinical effects of ω-3 fatty acid–containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancerHiroshi Miyata, Yuichiro� Doki, Osamu Shiraishi et al.|Nutrition|2016Cited by 54
Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal CancerOsamu Shiraishi, Takushi Yasuda, Makoto Yamasaki et al.|Oncology|2016Cited by 44
Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal CancerHiroshi Miyata, Yuichiro� Doki, Keijirou Sugimura et al.|Annals of Surgical Oncology|2018Cited by 42
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinomaTomoki Makino, Takushi Yasuda, Makoto Yamasaki et al.|British Journal of Cancer|2022Cited by 40